INTEGRATED MULTI-OMICS ANALYSIS REVEALS MOLECULAR SUBTYPES WITH PROGNOSTIC AND THERAPEUTIC RELEVANCE IN AML

EHA Library, Habib Hamidi, 4159748

ENGINEERING MESENCHYMAL STEM CELLS WITH HELIX2-TAT PEPTIDES FOR PHILADELPHIA+ LEUKEMIA AMELIORATION

EHA Library, Afsar Ali Mian, 4159750

IDENTIFICATION OF NOVEL THERAPEUTIC COMPOUNDS FOR THE TREATMENT OF INFANT PATIENTS WITH KMT2A-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA BY DRUG REPURPOSING

EHA Library, Simona Procopio, 4159752

AN INTEGRATIVE, MULTIOMIC ANALYSIS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Olga Krali, 4159753

TARGETING LEUKEMIA-ASSOCIATED MACROPHAGES WITHIN THE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BONE MARROW NICHE USING A CARCIK CELL-BASED APPROACH

EHA Library, Alessandra Fallati, 4159754

NON-GENETIC FACTORS CONTRIBUTING TO TREATMENT RESPONSE IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Sanni Moisio, 4159757

BCP-ALL INDUCED IMMUNE REPRESSION CAUSES FAILURE OF BLINATUMOMAB-DEPENDENT KILLING AT INITIAL DIAGNOSIS

EHA Library, Babette D. J. Hoen, 4159759

RNA SEQUENCING IMPROVES MOLECULAR CHARACTERIZATION OF A SINGLE-CENTRE PAEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA COHORT

EHA Library, Mercè Richarte-Franqués, 4159762

FREQUENCY OF VARIANT ALK-FUSIONS AND PROGNOSTIC IMPACT OF CLINICAL AND MOLECULAR FEATURES IN CHINESE PEDIATRIC ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)

EHA Library, Yonghong Zhang, 4159764

DISTINCT FUNCTIONAL AND COMPOSITIONAL PROPERTIES IN THE GUT MICROBIOME OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A SHOTGUN METAGENOMICS STUDY

EHA Library, Edoardo Muratore, 4159765

TARGETING FLT3 IN B-ALL: FROM GENOMIC INSIGHTS TO THERAPEUTIC APPLICATIONS

EHA Library, Anna Ferrari, 4159766

INVESTIGATING PREDNISONE-INDUCED SIGNALING PATHWAY CHANGES IN PEDIATRIC T-ALL

EHA Library, Daniela Kužílková, 4159767

ASSESSING THE EFFICACY OF NK CELLS IN COMBINATION WITH BH3-MIMETICS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Colin Fortner, 4159771

ACTIVIN A INFLUENCES THE CROSS-TALK BETWEEN B-CELL TYPE ACUTE LYMPHOBLASTIC CELLS AND MESENCHYMAL STROMAL CELLS MEDIATED BY THE RELEASE OF EXTRACELLULAR VESICLES

EHA Library, Erica Dander, 4159772

COHESINS: CROSSROAD BETWEEN CORNELIA DE LANGE SYNDROME AND CANCER PREDISPOSITION

EHA Library, Stefano Rebellato, 4159775

TARGETING M2-LIKE TUMOR-ASSOCIATED MACROPHAGES BY MEANS OF NEW TLR4 AGONISTS

EHA Library, Alice Martina Giussani, 4159778

BICISTRONIC CD19/CD22 CAR T-CELL THERAPY EXHIBITS CLINICAL ACTIVITIES IN RELAPSED OR REFRACTORY CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Hua Zhang, 4159780

HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION COMBINED WITH UMBILICAL CORD BLOOD VS. HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS: A MULTICENTER REAL-WORLD STUDY

EHA Library, Yifan Shen, 4159782

IKZF1PLUS GENOTYPE ACCELERATES T315I MUTAGENESIS IN ADULT BCR::ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Jin WANG, 4159783

PREDICTING HEMATOTOXICITY RISK AND OUTCOMES IN RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL): SHOULD HEMATOTOX MODELS BE CAR SPECIFIC RATHER THAN DISEASE SPECIFIC

EHA Library, Claire Roddie, 4159785

THE OUTCOMES FROM A REAL-WORLD STUDY OF INATICABTAGENE AUTOLEUCEL IN CHINESE PATIENTS WITH B-ALL

EHA Library, Hongsheng Zhou, 4159786

COMPARISON OF LONG-TERM OUTCOMES BETWEEN FLUMATINIB AND DASATINIB MAINTENANCE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Yi Yu, 4159792

OSTEONECROSIS AS A SIDE EFFECT OF A PEDIATRIC-BASED TREATMENT REGIMEN IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Felix Klingler, 4159794

IMMUNE RECONSTITUTION STABILITY AFTER CAR-T HAD AN IMPACT ON OUTCOMES OF B-ALL PATIENTS

EHA Library, Zhihuan Yang, 4159796

A PHASE 2 STUDY OF OLVEREMBATINIB FOR THE TREATMENT OF MYELOID/LYMPHOID NEOPLASMS WITH FGFR1 REARRANGEMENT

EHA Library, Wenzhi Cai, 4159797

COMPARISON OF DIFFERENT DOSES OF RABBIT ANTI-THYMOCYTE GLOBULIN (ATG-T) AND ANTI-T-LYMPHOCYTE GLOBULIN (ATLG) IN TBI-BASED MYELOABLATIVE CONDITIONING FOR HAPLOIDENTICAL TRANSPLANTATION IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Yue Lu, 4159799

SINUSOIDAL OBSTRUCTION SYNDROME AND OTHER OUTCOMES IN PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WHO RECEIVED INOTUZUMAB OZOGAMICIN BEFORE HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, David Marks, 4159800

IMPROVING LYMPHOPENIA AND REDUCING THE RISK OF INFECTION THROUGH THE INFUSION OF CD7 GENE KNOCK-OUT LYMPHOCYTES FOR R/R T-ALL AFTER CD7 CAR T CELL THERAPY

EHA Library, Jing Pan, 4159802

EXPLORATORY STUDY ON THE RELATIONSHIP BETWEEN THE EFFICACY OF BLINATUMOMAB TREATMENT AND T CELL FUNCTION IN PEDIATRIC B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA USING THE FULL-SPECTRUM FLOW CYTOMETRY ANALYSIS

EHA Library, Ruidong Zhang, 4159803

USP7 MUTATIONS PREDICT ADVERSE LONG-TERM OUTCOMES IN PEDIATRIC T CELL ACUTE LYMPHOBLASTIC LEUKAEMIA AND LYMPHOMA

EHA Library, fengfeng niu, 4159804

KTE-X19 IN RELAPSED OR REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN THE CHINESE POPULATION: A PHASE II MULTICENTER STUDY

EHA Library, Meng Lv, 4159810

VARS: A VENETOCLAX/AZACITIDINE SCRNA-SEQ RESISTANCE SIGNATURE ASSOCIATED WITH TREATMENT RESPONSE IN ACUTE MYELOID LEUKEMIA

EHA Library, Anne Merbach, 4159811

COMPREHENSIVE MULTI-OMICS PROFILING REVEALS THE DISTINCT EOMAST-LIKE CELLULAR SUBSET IN T(8;21) ACUTE MYELOID LEUKEMIA WITH CLINICAL SIGNIFICANCE

EHA Library, Yu Liu, 4159812

UNCOVERING CD180 AS A NOVEL MARKER AND THERAPEUTIC TARGET OF CHEMORESISTANCE AND RELAPSE IN KMT2A-REARRANGED PAEDIATRIC AML.

EHA Library, Madonna Eltoukhy, 4159815

A NOVEL ROLE FOR TRANSCRIPTION FACTOR NFE2 IN REGULATING REDOX RESPONSES AND CHEMOTHERAPY RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Anne Marie Staehle, 4159817

PROTEIN S-ACYLATION DYNAMICS PROVIDE METABOLIC FLEXIBILITY TO ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Nick van Gastel, 4159818

TARGETING ZEB1 TO ENHANCE MENIN-INHIBITOR SENSITIVITY IN KMT2A-MLLT3 ACUTE MYELOID LEUKEMIA THROUGH MODULATION OF MICRORNA-204

EHA Library, Liam MacPhee, 4159821

OVERCOMING VENETOCLAX RESISTANCE: SYNERGISTIC POTENTIAL OF RVU120, A CDK8/CDK19 INHIBITOR, IN COMBINATION TREATMENT.

EHA Library, Urszula Pakulska, 4159822

MULTIMODAL MACHINE LEARNING DECODES TRANSCRIPTION FACTORS-DRIVEN NK CELL DYSFUNCTION IN AML: A SINGLE-CELL TRANSCRIPTOMIC ROADMAP FOR PRECISION IMMUNOTHERAPY

EHA Library, jiaxiu Ma, 4159823

VENETOCLAX 50 MG WITH AZOLE VS. 400 MG WITHOUT AZOLE: COMPARABLE CLINICAL EFFICACY DESPITE LOWER DRUG EXPOSURE PROFILES—A PROSPECTIVE STUDY ON PHARMACOKINETICS, EFFICACY, AND TOXICITY IN NEWLY DIAGNOSED AML PATIENTS

EHA Library, Rudra Swain, 4159824

HARNESSING ENGINEERED INVARIANT NATURAL KILLER T CELLS (INKT CELLS) AGAINST CD117: A NOVEL STRATEGY FOR TREATING ACUTE MYELOID LEUKEMIA

EHA Library, chaiyaporn boonchalermvichian, 4159826

COMPUTATIONAL MEASURABLE RESIDUAL DISEASE ASSESSMENT IMPROVES RELAPSE PREDICTION IN ACUTE MYELOID LEUKEMIA: A RETROSPECTIVE VALIDATION IN THE HOVON-SAKK-132 TRIAL

EHA Library, Tim Mocking, 4159828

TARGETING MUTANT ISOCITRATE DEHYDROGENASE THROUGH FRUCTOSE METABOLISM

EHA Library, Angela Maria Savino, 4159829

KMT2E EXPRESSION DEFINES A SUBSET OF LEUKEMIC STEM CELLS WITH OXPHOS DEPENDENCE AND THERAPEUTIC SENSITIVITY TO RETINOIC ACID AND PARP1 INHIBITION

EHA Library, Luise A de A Simoes, 4159830

REFINING AML PATIENTS' KARYOTYPES USING OPTICAL GENOME MAPPING. UNRAVELING CRYPTIC ALTERATIONS AND DECIPHERING COMPLEX KARYOTYPES.

EHA Library, Neus Torres Hernández, 4159833

SORAFENIB REVERSES VENETOCLAX SECONDARY RESISTANCE IN ACUTE MYELOID LEUKAEMIA VIA DOWNREGULATION OF THE RAS-RAF-MEK-ERK SIGNALLING PATHWAY

EHA Library, zhangbiao long, 4159835

INTRACELLULAR SIGNALING SIGNATURES IN THE MONOCYTIC COMPARTMENT DISTINGUISH ACUTE MYELOID LEUKEMIA FROM HEALTHY PERIPHERAL BLOOD AND BONE MARROW

EHA Library, Oriol Castells, 4159840

LONG-READ SEQUENCING REVEALS THE LANDSCAPE OF ABERRANT SPLICING IN DDX41 MUTATED AML

EHA Library, Carolin Seeling, 4159841

PROTEIN ARGININE METHYLTRANSFERASE (PRMT2) IS INVOLVED IN JNK SIGNALING AND CYTOSKELETON REORGANIZATION BY COOPERATING WITH VAV1 AND WASP/WIPF1 IN ACUTE MYELOBLASTIC LEUKEMIA

EHA Library, Denis Masnikov, 4159842

IDH1/2-MUTATED AML: MOLECULAR PROFILE AND PROGNOSTIC IMPACT OF IDH1/2-MRD IN IDH1/2-MUTATED AML FROM THE FRENCH HAUTS-DE-FRANCE AML OBSERVATORY

EHA Library, Mélinda Dantec, 4159847

VENETOCLAX SYNERGIZES WITH HK2 INHIBITOR 2 - DG IN ACUTE MYELOID LEUKEMIA VIA THE ENDOPLASMIC RETICULUM STRESS PATHWAY.

EHA Library, Menghua Sun, 4159849

MULTILAYER ANALYSIS OF IL-7R DEPENDENCIES UNVEILS HISTONE DEACETYLASES AND SPHINGOSINE KINASES AS KEY PLAYERS IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Marta B. Fernandes, 4159745

HIGH METABOLIC ACTIVITY IN LEUKEMIC CELLS IS ASSOCIATED WITH MORE AGGRESSIVE PHENOTYPE AND REDUCED TREATMENT EFFICACY

EHA Library, Júlia Starková, 4159746

ENHANCING IMMUNOTHERAPY IN B-ALL: THE ROLE OF MTORC1-AKT-FOXO1 SIGNALING IN CD20 UPREGULATION MEDIATED BY MTORC1 INHIBITORS

EHA Library, Agnieszka Dąbkowska, 4159747

HIGH-RISK CLINICAL FEATURES AND POOR OUTCOMES IN PEDIATRIC PAX5R B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: FLT3 TARGETING AS A POTENTIAL NOVEL TREATMENT STRATEGY

EHA Library, Nicolò Peccatori, 4159749

DESIGNER PEPTIDES FOR THE TREATMENT OF DUX4-R+ ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Mara Salomè, 4159751

OPTIMIZING ASPARAGINASE HYPERSENSITIVITY MANAGEMENT: REAL-WORLD EVIDENCE ON ASPARAGINASE SWITCHING PRACTICES AND GUIDELINE ADHERENCE

EHA Library, Luke Maese, 4159755

DEVELOPMENT OF PRECLINICAL MODELS FOR THE EVALUATION OF CONVENTIONAL AND IN VIVO CAR-T THERAPIES

EHA Library, Hongyan Sun, 4159756

NFATC1 AND NFATC2 ARE KEY REGULATORS OF GLUCOCORTICOID RESISTANCE IN PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Giulia Veltri, 4159758

RESOLVING COMPLEX REARRANGEMENTS AND IMPROVING VARIANT ANALYSIS IN PEDIATRIC B-ALL USING OPTICAL GENOME MAPPING

EHA Library, Anna Bekő, 4159760

FERROPTOSIS: AN IRON-EXPLOITING STRATEGY TO TARGET ACUTE LYMPHOBLASTIC LEUKEMIA (FIEST-ALL)

EHA Library, Martina Maria Capelletti, 4159761

CD123 EXPRESSION AND OUTCOMES IN CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Eftichia Stiakaki, 4159763

OPTIMISING GENETIC SCREENS IN PRIMARY MLL-AF4 B-ALL CELLS

EHA Library, Shanissa Meah, 4159768

COMBINING MENIN INHIBITION (ZIFTOMENIB) WITH VENETOCLAX ENHANCES ANTI-LEUKEMIC ACTIVITY IN PRECLINICAL MODELS OF HUMAN KMT2AR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Marianna Giorgi, 4159769

SERUM FLT3 LIGAND AS A BIOMARKER OF DISEASE STATUS IN ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Nuno Borges, 4159770

MINIMAL RESIDUAL DISEASE ASSESSMENT BY DIGITAL DROPLET PCR USING PATIENT-SPECIFIC FUSION GENES IN PHILADELPHIA-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Deborah Cardinali, 4159774

SMARCA4 MUTATIONS AS RELAPSE DRIVERS FOR T CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL)

EHA Library, Violeta García-Hernández, 4159776

DECIPHERING B-ALL AND MSC INTERACTION: PATHWAYS TO CHEMORESISTANCE AND CELL CONTACT DYNAMICS

EHA Library, Emily Cutler, 4159777

DONOR-DERIVED, ALLOGENEIC CD19/CD22-CAR T CELLS WITH MYELOABLATIVE GRAFT-ENGINEERED ALLO-HCT FOR HIGH-RISK B-ALL

EHA Library, Snegha Ananth, 4159779

FIVE-YEAR SURVIVAL OUTCOMES OF PATIENTS (PTS) WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL) TREATED WITH BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) IN ZUMA-3

EHA Library, Olalekan Oluwole, 4159781

REAL-WORLD EFFECTIVENESS AND SAFETY IN ADULTS WITH MINIMAL RESIDUAL DISEASE-POSITIVE OR RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA TREATED WITH BLINATUMOMAB ACROSS 13 EUROPEAN COUNTRIES

EHA Library, Sabina Chiaretti, 4159784

PERFORMANCE OF BLINATUMOMAB FOR MRD TREATMENT AND BRIDGE TO ALLO-SCT IN PH-NEGATIVE B-ALL PATIENTS TREATED WITH PEDIATRIC INSPIRED LAL1913 PROGRAM (SUBANALYSIS OF THE CAMPUS-ALL LAL1913 STUDY).

EHA Library, Anna Candoni, 4159788

EXPRESSION OF THE THYMIC STROMAL LYMPHOPOIETIN RECEPTOR (TSLPR) IS CLOSELY ASSOCIATED WITH CYTOKINE RECEPTOR-LIKE FACTOR 2 (CRLF2) REARRANGED PHILADELPHIA (PH) LIKE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

EHA Library, Julian Liebaert, 4159790

FRONTLINE CHEMOTHERAPY-FREE COMBINATION OF OLVEREMBATINIB WITH VENETOCLAX AND AZACITIDINE IN NEWLY DIAGNOSED PH+ ACUTE LYMPHOBLASTIC LEUKEMIA:PRELIMINARY OUTCOMES OF A PROSPECTIVE STUDY

EHA Library, Xiaowen Tang, 4159791

A PROSPECTIVE STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED BCR::ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: RJ-ALL2020.2A TRIAL

EHA Library, Weiyang Liu, 4159793

INTEGRATED VENETOCLAX WITH IMMUNOCHEMOTHERAPY IN OLDER OR UNFIT PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): A PHASE 2 MULTI-CENTER CLINICAL TRIAL

EHA Library, Runxia Gu, 4159795

EXCELLENT LONG-TERM OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR RELAPSED/REFRACTORY PH+ B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FAILING TO ACHIEVE COMPLETE MOLECULAR REMISSION

EHA Library, Yanzhi Song, 4159798

FLOW CYTOMETRY MINIMAL RESIDUAL DISEASE STATUS COMBINED WITH CYTOGENETICS RISK CLASSIFICATION PREDICTS SURVIVAL AND RELAPSE RISK IN ADOLESCENTS AND ADULTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Jiayan Gu, 4159801

FULL PEDIATRIC INDUCTION INCLUDING HIGH DOSES OF ASPARAGINASES RESULTS IN EXCELLENT OUTCOME IN ADULT ALL PATIENTS AGED UP TO 60 YEARS, ESPECIALLY AMONG T-ALL PATIENTS

EHA Library, Paola Minetto, 4159805

INVASIVE FUNGAL DISEASE IN CHILDREN ALL RECEIVING CHEMOTHERAPY-AN ANALYISIS OF MUTI-CENTER CLINICAL TRIAL CCCG-ALL-2015

EHA Library, Xuedong Wu, 4159806

REAL WORLD ANALYSIS OF OUTCOMES USING A MODIFIED DFCI PROTOCOL FOR ADULTS WITH BCR-ABL NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA - IMPACT OF MRD

EHA Library, Joseph Brandwein, 4159808

SINGLE-CELL MULTIOMICS DATA-DRIVEN MEASURABLE RESIDUAL DISEASE (MRD) ASSESSMENT USING MULTIDIMENSIONAL FLOW CYTOMETRY (MFC) IN ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Carmen Gonzalez, 4159813

TRACKING THE STEMNESS MECHANISMS IN REFRACTORY MECOM REARRANGED ACUTE MYELOID LEUKEMIAS AT SINGLE CELL RESOLUTION

EHA Library, Ilse Kaaja, 4159814

INHIBITION OF CSF1R-CSF1 AXIS WITH AXATILIMAB EFFECTIVELY TARGETS LEUKEMIA STEM CELLS AND MONOCYTES IN BH3 MIMETICS-RESISTANT AML

EHA Library, Bing Carter, 4159816

REM-422, A SMALL MOLECULE MYB MRNA DEGRADER, DEMONSTRATES ANTI-LEUKEMIC ACTIVITY AS A MONOTHERAPY AND IN COMBINATION WITH STANDARDS OF CARE IN PRECLINICAL MODELS OF AML

EHA Library, Charles Kung, 4159819

THE GLYCOSYLTRANSFERASE MGAT1 IS A VULNERABILITY IN AML IN VITRO AND IN VIVO AND ALTERS THE AFFINITIES OF ANTI-EPITOPE DIRECTED IMMUNOTHERAPIES

EHA Library, Cosima Nather, 4159820

LOW-TOXICITY ANTIBODY DRUG-CONJUGATE THERAPY FOR AML PATIENTS TARGETING THE GLYCOSAMINOGLYCAN ONCOFETAL CHONDROITIN SULFATE

EHA Library, Priya Khadgawat, 4159825

GLYCOLYSIS-DRIVEN IMMUNE EVASION IN ACUTE MYELOID LEUKEMIA IMPAIRS MACROPHAGE-MEDIATED CLEARANCE

EHA Library, Isabel Weinhauser, 4159827

OVERCOMING VENETOCLAX RESISTANCE BY SELECTIVE PARP1 INHIBITION IN ACUTE MYELOID LEUKEMIA

EHA Library, Justinas Daraskevicius, 4159831

PRL2 IS ESSENTIAL FOR THE MAINTENANCE OF LEUKEMIA STEM CELL IN MLL GENE REARRANGEMENT ACUTE MYELOID LEUKEMIA VIA INTERACTING WITH KDM2B

EHA Library, Hongxia Chen, 4159832

LEVELS OF 91 CIRCULATING INFLAMMATORY PROTEINS AND RISK OF ACUTE MYELOID LEUKEMIA : A MENDELIAN RANDOMIZATION STUDY

EHA Library, Tao Wu, 4159836

CD39 EXPRESSION ON AML BLASTS INFLUENCES TH1 CELL DIFFERENTIATION AND PROLIFERATION VIA WNT6 AND SPP1-CD44 SIGNALING PATHWAYS WITHIN THE BONE MARROW MICROENVIRONMENT

EHA Library, Hanheng Mai, 4159837

MESENCHYMAL STROMAL CELLSPROTECT ACUTE MYELOID LEUKAEMIA CELLS FROM VENETOCLAX-INDUCED APOPTOSIS THROUGH A CD90-MEDIATED ADHESION PATHWAY

EHA Library, Karyna Volkava, 4159838

MOLECULAR PROFILING OF PEDIATRIC AML: A NEXT-GENERATION SEQUENCING APPROACH IN A SINGLE-CENTER COHORT

EHA Library, Alba Crespo-Carrasco, 4159839

TP53-MUTATED AML: A MULTI-OMICS APPROACH TO UNDERSTAND HETEROGENEITY AND THERAPEUTIC VULNERABILITIES

EHA Library, Ana RIO-MACHIN, 4159843

GENOMIC AND TRANSCRIPTOMIC DETERMINANTS ON CLINICAL OUTCOME IN AML PATIENTS WITH DNMT3A MUTATION

EHA Library, Feng-Ming Tien, 4159844

IDENTIFICATION OF NOVEL HIGH-RISK SUBTYPES BY DEVELOPMENT OF MULTI-OMICS-BASED MOLECULAR CLASSIFICATION TO GUIDE PRECISION MEDICINE IN ACUTE MYELOID LEUKEMIA

EHA Library, Runyu Yang, 4159845

SINGLE CELL SEQUENCING DECIPHERING THE HETEROGENEOUS LANDSCAPE OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM WITH NOVEL MYB-ZFAT FUSION GENE

EHA Library, Ruijuan Li, 4159846

WOGONIN INDUCES APOPTOTIC CELL DEATH THROUGH PI3K/AKT AND MAPK/ ERK PATHWAYS AND SYNERGIZES WITH VENETOCLAX IN ACUTE MYELOID LEUKEMIA

EHA Library, Xia Jiang, 4159848

PLINABULIN AND SELUMETINIB INDUCE AAMS REPROGRAMMING INTO M1-LIKE MACROPHAGES AND REDUCE AML CELL VIABILITY

EHA Library, Lucio Henrique Sousa Pinheiro, 4159850